CUSIP: 02290A102
Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
37,072,853
-
Share change
-
+19,148,644
-
Total reported value
-
$330,687,308
-
Put/Call ratio
-
15%
-
Price per share
-
$8.92
-
Number of holders
-
30
-
Value change
-
+$178,415,630
-
Number of buys
-
25
-
Number of sells
-
9
Quarterly Holders Quick Answers
What is CUSIP 02290A102?
CUSIP 02290A102 identifies AMAM - AMBRX BIOPHARMA INC - SPONSORED ADS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2023
-
Previous quarter:
Q4 2022
Recent filing periods for CUSIP 02290A102:
Institutional Holders of AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) as of Q1 2023
As of 31 Mar 2023,
AMBRX BIOPHARMA INC - SPONSORED ADS (AMAM) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,072,853 shares.
The largest 10 holders included
Darwin Global Management, Ltd., Cormorant Asset Management, LP, COMMODORE CAPITAL LP, D. E. Shaw & Co., Inc., VR Adviser, LLC, FMR LLC, CITADEL ADVISORS LLC, Artal Group S.A., FARALLON CAPITAL MANAGEMENT LLC, and Ghost Tree Capital, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.